New research shows that genetic tests can now help predict which heart patients need higher doses of a common anti-clotting drug. Jessica Mega, HMS assistant professor of medicine at Brigham and Women’s Hospital, is the author of the study. Christopher Cannon, HMS associate professor of medicine at Brigham and Women’s Hospital, is also quoted.
Trending News
Search for Babesiosis Treatment Gets a New Map
New clues to help fight tick-borne disease
Can an AI ‘Co-Scientist’ Accelerate Cancer Research?
Nearly $7 million funds agentic AI tools to assist investigations into cancer’s most pressing…
First Large-Scale Study Shows How Doctors Use AI in Medicine
Which practitioners use artificial intelligence in the clinic, and what do they ask?